Stocks and InvestingStocks and Investing
Thu, February 23, 2023
Wed, February 22, 2023
Tue, February 21, 2023

Ben Hendrix Maintained (AMED) at Buy with Decreased Target to $111 on, Feb 21st, 2023


Published on 2024-10-28 01:46:46 - WOPRAI, Ben Hendrix
  Print publication without navigation


Ben Hendrix of RBC Capital, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $114 to $111 on, Feb 21st, 2023.

Ben has made no other calls on AMED in the last 4 months.



There are 12 other peers that have a rating on AMED. Out of the 12 peers that are also analyzing AMED, 3 agree with Ben's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $95 on, Thursday, February 16th, 2023
  • Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $85 on, Thursday, January 5th, 2023
  • John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022


These are the ratings of the 9 analyists that currently disagree with Ben


  • Mark Miller of "Benchmark" Maintained at Strong Buy with Decreased Target to $115 on, Thursday, February 16th, 2023
  • Bill Sutherland of "Benchmark" Reiterated at Strong Buy and Held Target at $120 on, Monday, February 13th, 2023
  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Decreased Target to $115 on, Monday, January 23rd, 2023
  • Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $125 on, Thursday, January 19th, 2023
  • Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $139 on, Monday, October 31st, 2022
  • David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $130 on, Friday, October 28th, 2022
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $145 on, Friday, October 28th, 2022
  • Sarah James of "Barclays" Maintained at Buy with Decreased Target to $126 on, Friday, October 28th, 2022
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022